Shanghai Yizhong Pharmaceutical Co. Ltd.SSE: 688091

(688091)"Shanghai Yizhong Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of Completion of First Dosing in the First Dose Cohort of the Phase I Clinical Trial of Innovative Drug YXC-001

· Issued by Shanghai Yizhong Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688091 ·

On 6ix: 6ix.com/news/688091shanghai-yizhong-pharmaceutical-co-ltdannouncement-on-voluntary-disclosure-of-completion-of-first-dosing-in-the-first-dose-cohort-of-the-phase-i-clinical-trial-of-innovative-drug-yxc-001

Announcement on Voluntary Disclosure of Completion of First Dosing in the First Dose Cohort of the Phase I Clinical Trial of Innovative Drug YXC-001

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Shanghai Yizhong Pharmaceutical Co. Ltd. on 6ix

Story so far

Earlier from Shanghai Yizhong Pharmaceutical

All Shanghai Yizhong Pharmaceutical news releases